Surgalign Holdings, Inc.
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2023 | 12/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -18.59% | 1.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.59% | 1.96% | |||
| Cost of Revenue | -39.62% | 91.32% | |||
| Gross Profit | 0.06% | -27.91% | |||
| SG&A Expenses | -5.80% | -5.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.50% | 5.34% | |||
| Operating Income | 6.00% | -10.77% | |||
| Income Before Tax | 110.58% | -312.92% | |||
| Income Tax Expenses | 109.96% | -3,613.16% | |||
| Earnings from Continuing Operations | 110.60% | -297.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 110.60% | -297.75% | |||
| EBIT | 6.00% | -10.77% | |||
| EBITDA | 6.56% | -12.10% | |||
| EPS Basic | 108.90% | -295.31% | |||
| Normalized Basic EPS | -3.47% | 56.86% | |||
| EPS Diluted | 99.50% | -295.06% | |||
| Normalized Diluted EPS | 37.29% | 56.86% | |||
| Average Basic Shares Outstanding | 19.05% | 0.62% | |||
| Average Diluted Shares Outstanding | 96.44% | 0.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||